PTEN Up-Regulates the Tumor Metastasis Suppressor Gene Drg-1 in Prostate and Breast Cancer
- 1 November 2004
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 64 (21) , 7655-7660
Abstract
PTEN (phosphatase and tensin homologue deleted on chromosome 10) has been shown to be inactivated in a wide variety of cancers, and the role of this gene as a tumor suppressor has been well established. On the other hand, results of recent animal studies as well as clinical evidence indicate that PTEN is also involved in tumor metastasis suppression. Although PTEN is known to play a key role in controlling cell growth and apoptosis, how PTEN exerts the metastasis suppressor function remains largely unknown. Recently, a microarray analysis identified the Drg-1 gene (differentiation related gene 1) as one of the potential targets of PTEN. The Drg-1 gene has been shown to suppress tumor metastasis in animal models of prostate and colon cancer, and the expression of this gene is significantly reduced with advancement of prostate and breast cancers in clinical setting. In this study, we explored the possibility that PTEN controls tumor metastasis by regulating the expression of the Drg-1 gene. Our results indicate that overexpression of PTEN significantly augments the endogenous expression of Drg-1 protein, whereas inhibition of PTEN by small interfering RNA decreases Drg-1 in a dose- and time-dependent manner. We also found that the control of the Drg-1 gene by PTEN seems to be at the transcriptional level, and that a phospho-Akt inhibitor restores the Drg-1 expression, indicating that PTEN controls Drg-1 by an Akt-dependent pathway. Consistent with these results, our immunohistochemical analysis revealed that PTEN expression correlates significantly with Drg-1 in both prostate and breast cancer cases. Furthermore, combination of the two markers, PTEN and Drg-1, emerged as a significantly better predictor of prostate and breast cancer patient survival than either marker alone.Keywords
This publication has 20 references indexed in Scilit:
- Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progressionOncogene, 2004
- Regulation of Cell Migration by the C2 Domain of the Tumor Suppressor PTENScience, 2004
- The phosphatidylinositol‐3 kinase pathway regulates bladder cancer cell invasionBJU International, 2003
- Pten Dose Dictates Cancer Progression in the ProstatePLOS Biology, 2003
- PTEN expression is associated with prognosis for patients with advanced endometrial carcinoma undergoing postoperative chemotherapyInternational Journal of Cancer, 2002
- RETRACTED ARTICLE: Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTENOncogene, 2001
- Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathwayOncogene, 2001
- Loss of Expression of the PTEN Gene Protein Product Is Associated with Poor Outcome in Breast CancerLaboratory Investigation, 2001
- Mutation ofPten/Mmac1in mice causes neoplasia in multiple organ systemsProceedings of the National Academy of Sciences, 1999
- PTEN , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate CancerScience, 1997